In order to enhance transparency, a number of changes are being introduced on this Register, notably by improving data availability and reliability. It is expected that this process will be completed by 31 December 2016. Until then, information published on individual expert groups and/or on expert group members may still be missing, be inaccurate or incomplete.
Group Details - Other Similar Entity Return to News section
Print as PDF
Details
Additional Information
Subgroups
Statistics
Members
Name:
Consultative Committee for the implementation of Directive 89/105/EEC (X01312)
Active
Group which operates on a permanent basis
Abbreviation:
Transparency Committee
Policy Area:
Enterprise
Lead DG:
GROW - DG Internal Market, Industry, Entrepreneurship and SMEs
Type:
Formal, Permanent
Scope:
Limited
Mission:
The Transparency Committee is a consultative Committee established by Article 10 of Directive 89/105/EEC relating to the Transparency of measures regulating the pricing of medicinal products and their inclusion in the scope of national health insurance systems (OJ N°40 of 11.2.1989, p. 8). Its main mission is to discuss issues relating to the application of the directive, including any question brought up by the Commission or at the request of a Member State.
Task:
Coordinate with Member States, exchange of views
Provides expertise to the Commission when preparing implementing measures, i.e. before the Commission submits these draft measures to a comitology committee
Composition:
Third Countries (Public affairs, Public health), Type D - Member State Authority
Contact:
GROW-D3@ec.europa.eu
Publication in RegExp:
14 Jun 2006
Creating Act:
Article 10 of Directive 89/105/EEC
Link to Website:
Last updated:
27 Sep 2016
Home   -   top